Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1995 Apr;40(4):219-27.
doi: 10.1007/BF01519895.

Biological response modifiers (BRM) as antigens. III. T cell lines specific for BRM kill tumor cells in a BRM-specific manner

S Ozaki  1 , T Okazaki, K Nakao
Affiliations

Biological response modifiers (BRM) as antigens. III. T cell lines specific for BRM kill tumor cells in a BRM-specific manner

S Ozaki et al. Cancer Immunol Immunother. 1995 Apr.

Abstract

In order to investigate tumoricidal effector cells in therapy by biological response modifiers (BRM) such as Propionibacterium acnes, bacillus Calmette-Guérin (BCG), Streptococcus pyogenes and a protein-bound polysaccharide (PSK), we established T cell lines specific for each BRM from BALB/c mice immunized with the corresponding BRM. These T cell lines proliferated and produced interleukin-2 (IL-2) and/or IL-4, but only in the presence of the relevant BRM and BALB/c spleen cells as the antigen and antigen-presenting cells respectively. Cross-functional experiments indicated that each BRM acts as a nominal antigen, but not as a non-specific immunostimulator. In addition, the T cell lines killed Ia-positive syngeneic B lymphoma cells, but only in the presence of the relevant BRM. These experiments excluded the possibility of cytotoxic effects by each BRM. The T cell lines and clones also killed Ia-negative bystander target cells, but only in the presence of both a relevant antigen and antigen-presenting cells. The T cell clones specific for S. pyogenes or P. acnes tested were Thy1+, L3T4+ and Lyt2-. These results indicate that some BRM exert tumoricidal activity by inducing T cells that recognize them as an antigen and kill tumor cells in an antigen-specific manner. The T cells killed tumor targets in either a tumor-necrosis-factor(TNF)-dependent or a TNF-independent manner. The mediator of the latter pathway remains to be elucidated.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Oldham RK. Biological response modifiers. J Natl Cancer Inst. 1983;70:789. - PubMed
    1. Mizutani Y, Nio Y, Fukumoto M, Yoshida O. Enhanced antitumor effect of bacillus Calmette-Guerin in combination with fibrinogen on urinary bladder tumor. J Urol. 1994;151:1420. - PubMed
    1. Shu SY, Chou T, Sakai K. Lymphocytes generated by in vivo priming and in vitro sensitization demonstrate therapeutic efficacy against a murine tumor that lacks apparent immunogenicity. J Immunol. 1989;143:740. - PubMed
    1. Uchida A, Micksche M. Lysis of fresh tumor cells by autologous peripheral blood and pleural effusion lymphocytes activated by OK-432. J Natl Cancer Inst. 1983;71:673. - PubMed
    1. Saito M, Ichimura O, Kataoka M, Moriya Y, Ueno K, Sugawara Y, Nanjou M, Ishida N. Pronounced antitumor effect of LAK-like cells induced in the peritoneal cavity of mice after intraperitoneal injection of OK-432, a killed streptococcal preparation. Cancer Immunol Immunother. 1986;22:161. - PMC - PubMed

MeSH terms

LinkOut - more resources